{"date":"2025-12-15","count":17,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4745-2025-12-15-1850-19bsv3u","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-12-15","time":"18:50:07","subject":"公告本公司114年11月份自結應收帳款餘額及回收情形","clause":"第53款","fact_date":"2025-12-15","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-12-15 18:50，「公告本公司114年11月份自結應收帳款餘額及回收情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6999-2025-12-15-1827-1v4hapa","company_id":"6999","company":"瀚醫生技","market":"興櫃","industry":"生技醫療","date":"2025-12-15","time":"18:27:29","subject":"本公司董事會決議通過對子公司Han Biomedical GmbH之資金貸與債權轉增資","clause":"第44款","fact_date":"2025-12-15","cite_as":"公開資訊觀測站重大訊息：瀚醫生技（6999），2025-12-15 18:27，「本公司董事會決議通過對子公司Han Biomedical GmbH之資金貸與債權轉增資」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-12-15-1756-1g6i233","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-12-15","time":"17:56:38","subject":"公告本公司董事長異動","clause":"第6款","fact_date":"2025-12-15","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-12-15 17:56，「公告本公司董事長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-12-15-1754-1eynpr2","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-12-15","time":"17:54:09","subject":"本公司法人董事Digital Capital Inc.改派代表人","clause":"第6款","fact_date":"2025-12-15","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-12-15 17:54，「本公司法人董事Digital Capital Inc.改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2025-12-15-1727-g5o5zl","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2025-12-15","time":"17:27:15","subject":"公告本公司114年現金增資認股基準日相關事宜","clause":"第9款","fact_date":"2025-12-15","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2025-12-15 17:27，「公告本公司114年現金增資認股基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4163-2025-12-15-1720-1h039nn","company_id":"4163","company":"鐿鈦","market":"上櫃","industry":"生技醫療","date":"2025-12-15","time":"17:20:37","subject":"公告本公司董事長依董事會授權決定限制員工權利新股之增資基準日","clause":"第53款","fact_date":"2025-12-15","cite_as":"公開資訊觀測站重大訊息：鐿鈦（4163），2025-12-15 17:20，「公告本公司董事長依董事會授權決定限制員工權利新股之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2025-12-15-1644-d0z19z","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2025-12-15","time":"16:44:54","subject":"公告本公司董事會通過修訂動物止痛藥之授權合約","clause":"第10款","fact_date":"2025-12-15","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2025-12-15 16:44，「公告本公司董事會通過修訂動物止痛藥之授權合約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2025-12-15-1635-6evizb","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2025-12-15","time":"16:35:27","subject":"本公司受邀參加統一綜合證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2025-12-16","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2025-12-15 16:35，「本公司受邀參加統一綜合證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4737-2025-12-15-1545-1bi2fou","company_id":"4737","company":"華廣","market":"上市","industry":"生技醫療","date":"2025-12-15","time":"15:45:25","subject":"本公司受邀參加台新證券舉辦之法人說明會","clause":"第12款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：華廣（4737），2025-12-15 15:45，「本公司受邀參加台新證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6483-2025-12-15-1534-mdh4hg","company_id":"6483","company":"原創生醫","market":"興櫃","industry":"生技醫療","date":"2025-12-15","time":"15:34:49","subject":"本公司研發之用於上呼吸道給藥之組成物及其給藥方法(OBM-B01)向台灣衛福部食藥署(TFDA)提出一期人體臨床試驗審查申請(IND)","clause":"第44款","fact_date":"2025-12-15","cite_as":"公開資訊觀測站重大訊息：原創生醫（6483），2025-12-15 15:34，「本公司研發之用於上呼吸道給藥之組成物及其給藥方法(OBM-B01)向台灣衛福部食藥署(TFDA)提出一期人體臨床試驗審查」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6615-2025-12-15-1527-zxfqmi","company_id":"6615","company":"慧智","market":"上櫃","industry":"生技醫療","date":"2025-12-15","time":"15:27:40","subject":"慧智基因受邀參加福邦證券所舉辦之法人說明會","clause":"第12款","fact_date":"2025-12-17","cite_as":"公開資訊觀測站重大訊息：慧智（6615），2025-12-15 15:27，「慧智基因受邀參加福邦證券所舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7888-2025-12-15-1459-1kvcr9w","company_id":"7888","company":"麗寶新藥","market":"興櫃","industry":"生技醫療","date":"2025-12-15","time":"14:59:53","subject":"公告本公司受邀參加台新證券舉辦之興櫃前法人說明會","clause":"第9款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：麗寶新藥（7888），2025-12-15 14:59，「公告本公司受邀參加台新證券舉辦之興櫃前法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7888-2025-12-15-1450-8kc4mu","company_id":"7888","company":"麗寶新藥","market":"興櫃","industry":"生技醫療","date":"2025-12-15","time":"14:50:45","subject":"公告本公司自114年12月23日登錄興櫃買賣","clause":"第9款","fact_date":"2025-12-15","cite_as":"公開資訊觀測站重大訊息：麗寶新藥（7888），2025-12-15 14:50，「公告本公司自114年12月23日登錄興櫃買賣」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-12-15-1446-w12jjv","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-12-15","time":"14:46:31","subject":"本公司與新加坡國立大學醫院及新加坡科技研究局生物處理技術研究院簽署加速器型硼中子捕獲治療研發中心建置合作協議","clause":"第10款","fact_date":"2025-12-15","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-12-15 14:46，「本公司與新加坡國立大學醫院及新加坡科技研究局生物處理技術研究院簽署加速器型硼中子捕獲治療研發中心建置合作協議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-12-15-1433-lxsgi0","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-12-15","time":"14:33:03","subject":"更正本公司114年11月背書保證資訊揭露明細表(新增背保對象)","clause":"第51款","fact_date":"2025-12-15","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-12-15 14:33，「更正本公司114年11月背書保證資訊揭露明細表(新增背保對象)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2025-12-15-1409-1aq7iqo","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2025-12-15","time":"14:09:24","subject":"本公司受邀參加元大證券舉辦之法人說明會","clause":"第30款","fact_date":"2025-12-16","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2025-12-15 14:09，「本公司受邀參加元大證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2025-12-15-1341-1g7ukaw","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2025-12-15","time":"13:41:59","subject":"開發中新藥OBP-301向日本PMDA提出上市申請","clause":"第53款","fact_date":"2025-12-15","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2025-12-15 13:41，「開發中新藥OBP-301向日本PMDA提出上市申請」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}